Cancer Family
Lung Neoplasm
CI-CAN-00000221Explore in graph →
Non-malignant2,726 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000221Explore in graph →
Clinical trials
11,603 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00881296 | Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer(GEEP) | completed | Phase 2 | 60 | Hamamatsu UniversityOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00115518 | Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 30 | Heidelberg UniversityOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT00005989 | R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer | completed | Phase 2 | — | Mayo ClinicOTHER | 1 | Aug 4, 2011 | clinicaltrials |
| NCT00040638 | Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 40 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00047801 | Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 28 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00077883 | TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 50 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00708812 | Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 126 | Shandong Simcere-Medgenn Bio-pharmaceutical Co., LtdINDUSTRY | 1 | Jul 21, 2011 | clinicaltrials |
| NCT01282450 | Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 60 | Maastricht Radiation OncologyOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00293085 | An Open, Randomized, Multicentre, Phase II Pilot Study | completed | Phase 2 | 37 | Central European Cooperative Oncology GroupOTHER | 0 | Jun 23, 2011 | clinicaltrials |
| NCT00055978 | Celecoxib in Preventing Lung Cancer in Former Heavy Smokers | completed | Phase 2 | 112 | University of California, Los AngelesOTHER | 1 | Jun 20, 2011 | clinicaltrials |
| NCT00531401 | Study of Salirasib to Treat Non-Small Cell Lung Cancer | completed | Phase 2 | 71 | Concordia Pharmaceuticals, IncINDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
| NCT00343291 | A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC | completed | Phase 2 | 121 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 7, 2011 | clinicaltrials |
| NCT00614965 | Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV | completed | Phase 2 | 124 | Hellenic Oncology Research GroupOTHER | 1 | May 23, 2011 | clinicaltrials |
| NCT00002506 | Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | completed | Phase 2 | — | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00193336 | Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 60 | SCRI Development Innovations, LLCOTHER | 0 | May 3, 2011 | clinicaltrials |
| NCT00317200 | A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer | completed | Phase 2 | 34 | Hoosier Cancer Research NetworkOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT00403403 | A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) | completed | Phase 2 | 102 | Genentech, Inc.INDUSTRY | 0 | Apr 29, 2011 | clinicaltrials |
| NCT01024062 | Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 60 | Bristol-Myers SquibbINDUSTRY | 0 | Apr 25, 2011 | clinicaltrials |
| NCT00003125 | Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | completed | Phase 2 | 24 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00687817 | Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 49 | Peregrine PharmaceuticalsINDUSTRY | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00057798 | Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery | completed | Phase 2 | 21 | Roswell Park Cancer InstituteOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT00372775 | Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases | completed | Phase 2 | 66 | PfizerINDUSTRY | 4 | Feb 24, 2011 | clinicaltrials |
| NCT00819728 | Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 35 | SanofiINDUSTRY | 1 | Jan 11, 2011 | clinicaltrials |
| NCT00003269 | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 20 | Scripps HealthOTHER | 1 | Jan 10, 2011 | clinicaltrials |
| NCT00609518 | A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 2 | 111 | Eli Lilly and CompanyINDUSTRY | 4 | Dec 28, 2010 | clinicaltrials |
| NCT00321815 | Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer | completed | Phase 2 | 43 | PfizerINDUSTRY | 1 | Dec 23, 2010 | clinicaltrials |
| NCT00061451 | Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 22, 2010 | clinicaltrials |
| NCT00192036 | Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer | completed | Phase 2 | 49 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 9, 2010 | clinicaltrials |
| NCT00434668 | Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer(TOLEDO) | completed | Phase 2 | 99 | University Hospital, AntwerpOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00156286 | Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC | completed | Phase 2 | 20 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 16, 2010 | clinicaltrials |
| NCT01222936 | LBH Phase II in Small Cell Lung Cancer (SCLC) | completed | Phase 2 | 21 | Southern Europe New Drug OrganizationOTHER | 2 | Oct 18, 2010 | clinicaltrials |
| NCT00101920 | ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | 50 | AmgenINDUSTRY | 0 | Oct 15, 2010 | clinicaltrials |
| NCT00350792 | Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients | completed | Phase 2 | 62 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00430261 | Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma | completed | Phase 2 | 20 | Swedish Medical CenterOTHER | 1 | Oct 6, 2010 | clinicaltrials |
| NCT00085813 | Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | GlaxoSmithKlineINDUSTRY | 3 | Oct 4, 2010 | clinicaltrials |
| NCT00315185 | Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer | completed | Phase 2 | 53 | Fox Chase Cancer CenterOTHER | 1 | Sep 23, 2010 | clinicaltrials |
| NCT00925210 | Bronchoscopic Approach to the Peripheral Lung Nodule - An Alternative Approach | completed | Phase 2 | 60 | University of CalgaryOTHER | 1 | Sep 14, 2010 | clinicaltrials |
| NCT00409006 | Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 3 | Sep 9, 2010 | clinicaltrials |
| NCT00312819 | Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer | completed | Phase 2 / Phase 3 | 60 | Hadassah Medical OrganizationOTHER | 1 | Aug 31, 2010 | clinicaltrials |
| NCT00544960 | A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer | completed | Phase 2 | 106 | Ascenta TherapeuticsINDUSTRY | 3 | Aug 27, 2010 | clinicaltrials |
| NCT00397293 | Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 36 | Ascenta TherapeuticsINDUSTRY | 3 | Aug 24, 2010 | clinicaltrials |
| NCT00276588 | Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 46 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00673569 | Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment | completed | Phase 2 | 40 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT01058785 | Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer | completed | Phase 2 | 75 | NovaRx CorporationINDUSTRY | 1 | Jul 29, 2010 | clinicaltrials |
| NCT00193388 | Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer | completed | Phase 2 | 100 | SCRI Development Innovations, LLCOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT00193401 | Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer | completed | Phase 2 | 40 | SCRI Development Innovations, LLCOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT00826852 | Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax | completed | Phase 2 | 49 | SanofiINDUSTRY | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00453167 | Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer | completed | Phase 2 | 35 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 12, 2010 | clinicaltrials |
| NCT00316225 | Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen | completed | Phase 2 | 31 | Eli Lilly and CompanyINDUSTRY | 3 | Jul 9, 2010 | clinicaltrials |
| NCT00344773 | First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation | completed | Phase 2 | 46 | AstraZenecaINDUSTRY | 1 | Jun 29, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Sep 7, 2011source: clinicaltrials